Molecular predictors of gemcitabine response in pancreatic cancer

doi:10.4251/wjgo.v3.i11.153

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6432)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

381

HTML

5766

Figures (1-3)

285

Sum=6432

Nov 15, 2011 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (60)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Nov 15, 2011; 3(11): 153-164
Published online Nov 15, 2011. doi: 10.4251/wjgo.v3.i11.153

Full Size Figure Download Figure

Figure 3 Simplified representation of the web that regulates epithelial to mesenchymal transition or the reverse process mesenchymal to epithelial transition. Epithelial to mesenchymal transition (EMT) promotion is associated with gemcitabine resistance. Arrows denote up-regulation or activation and т type joinings denote down-regulation or inhibition. MET: Mesenchymal to epithelial transition; ZEB: Zinc finger E-box binding; TGFβ: Transforming growth factor β; NF-κB: Nuclear factor-κB.

Citation: Voutsadakis IA. Molecular predictors of gemcitabine response in pancreatic cancer. World J Gastrointest Oncol 2011; 3(11): 153-164
URL: https://www.wjgnet.com/1948-5204/full/v3/i11/153.htm
DOI: https://dx.doi.org/10.4251/wjgo.v3.i11.153